69
Participants
Start Date
July 31, 2001
Primary Completion Date
August 31, 2004
Study Completion Date
May 31, 2008
epirubicin hydrochloride
gemcitabine hydrochloride
CCOP - Upstate Carolina, Spartanburg
Mayo Clinic - Jacksonville, Jacksonville
MBCCOP - Gulf Coast, Mobile
CCOP - Michigan Cancer Research Consortium, Ann Arbor
CCOP - St. Vincent Hospital Cancer Center, Green Bay, Green Bay
CCOP - Metro-Minnesota, Saint Louis Park
CCOP - Duluth, Duluth
Mayo Clinic Cancer Center, Rochester
Coborn Cancer Center, Saint Cloud
CCOP - Sioux Community Cancer Consortium, Sioux Falls
Rapid City Regional Hospital, Rapid City
CCOP - Merit Care Hospital, Fargo
CCOP - Illinois Oncology Research Association, Peoria
CCOP - Carle Cancer Center, Urbana
CCOP - Missouri Valley Cancer Consortium, Omaha
CCOP - Ochsner, New Orleans
CCOP - Mayo Clinic Scottsdale Oncology Program, Scottsdale
CCOP - Cedar Rapids Oncology Project, Cedar Rapids
CCOP - Iowa Oncology Research Association, Des Moines
Siouxland Hematology-Oncology, Sioux City
CCOP - Wichita, Wichita
Medcenter One Health System, Bismarck
CCOP - Toledo Community Hospital, Toledo
CCOP - Geisinger Clinic and Medical Center, Danville
National Cancer Institute (NCI)
NIH
Alliance for Clinical Trials in Oncology
OTHER